← All trials
NCT05121909
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2021
- Primary completion
- Feb 25, 2022
- Completion date
- Feb 25, 2022
- First posted
- Nov 16, 2021
- Last posted
- Nov 16, 2021
- Enrollment
- 288
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Johnson and JohnsonLead sponsor
- All Sum Research Center Ltd.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.